Atria Wealth Solutions Inc. Boosts Stock Position in Church & Dwight Co., Inc. (NYSE:CHD)

Atria Wealth Solutions Inc. raised its position in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 0.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,124 shares of the company’s stock after purchasing an additional 110 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Church & Dwight were worth $1,270,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the company. Holocene Advisors LP purchased a new position in shares of Church & Dwight in the third quarter worth $104,795,000. State Street Corp increased its holdings in Church & Dwight by 8.0% in the 3rd quarter. State Street Corp now owns 13,116,334 shares of the company’s stock worth $1,373,542,000 after buying an additional 969,006 shares in the last quarter. World Investment Advisors LLC purchased a new position in Church & Dwight in the 3rd quarter worth about $58,338,000. Barclays PLC lifted its stake in Church & Dwight by 63.9% during the 3rd quarter. Barclays PLC now owns 1,106,131 shares of the company’s stock valued at $115,832,000 after acquiring an additional 431,257 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of Church & Dwight by 5.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 8,016,345 shares of the company’s stock valued at $839,472,000 after acquiring an additional 429,863 shares during the last quarter. 86.60% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Church & Dwight

In other Church & Dwight news, EVP Michael Read acquired 1,100 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was bought at an average price of $106.82 per share, for a total transaction of $117,502.00. Following the acquisition, the executive vice president now directly owns 2,505 shares in the company, valued at $267,584.10. The trade was a 78.29 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Rick Spann sold 39,520 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $112.00, for a total value of $4,426,240.00. Following the completion of the transaction, the executive vice president now directly owns 4,973 shares in the company, valued at approximately $556,976. This trade represents a 88.82 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 49,522 shares of company stock worth $5,487,555 in the last three months. Insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CHD. Truist Financial boosted their price objective on shares of Church & Dwight from $110.00 to $115.00 and gave the company a “buy” rating in a report on Monday, February 3rd. Piper Sandler lowered their price target on Church & Dwight from $128.00 to $126.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Barclays raised their price target on Church & Dwight from $90.00 to $93.00 and gave the stock an “underweight” rating in a research note on Tuesday, February 4th. Wells Fargo & Company upped their price objective on Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $105.00 target price on shares of Church & Dwight in a research report on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $111.47.

Church & Dwight Price Performance

Shares of NYSE:CHD opened at $105.40 on Monday. The company has a market capitalization of $25.93 billion, a P/E ratio of 44.47, a P/E/G ratio of 3.32 and a beta of 0.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.70 and a quick ratio of 1.24. The firm’s 50 day simple moving average is $105.35 and its two-hundred day simple moving average is $104.74. Church & Dwight Co., Inc. has a 1-year low of $96.35 and a 1-year high of $113.50.

Church & Dwight (NYSE:CHD) last issued its earnings results on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter last year, the business earned $0.65 earnings per share. Research analysts expect that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Friday, February 14th will be issued a $0.295 dividend. The ex-dividend date is Friday, February 14th. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.12%. Church & Dwight’s dividend payout ratio (DPR) is 49.79%.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.